Pediatric Chronic Kidney Disease Safety and Efficacy

This study has suspended participant recruitment.
(Dosing of IP was suspended due to a case of severe hypocalcemia in an enrolled subject. The study remains suspended pending discussions with the FDA)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01277510
First received: January 13, 2011
Last updated: July 17, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)